Company Growth (employees)
Zimmer Biomet was founded in 1927 and is headquartered in Warsaw, US
Zimmer Biomet Office Locations
Zimmer Biomet has an office in Warsaw
Warsaw, US (HQ)
345 E Main St
Zimmer Biomet Data and Metrics
Zimmer Biomet Financial Metrics
Zimmer Biomet's revenue was reported to be $7.7 b in FY, 2016 which is a 28% increase from the previous period.
USD
Revenue (FY, 2016) | 7.7 b |
Revenue growth (FY, 2015 - FY, 2016), % | 28% |
Gross profit (FY, 2016) | 5.3 b |
Gross profit margin (FY, 2016), % | 69% |
Net income (FY, 2016) | 304.6 m |
EBIT (FY, 2016) | 825.9 m |
Market capitalization (20-Jul-2017) | 26.1 b |
Closing share price (20-Jul-2017) | 131.1 |
Cash (31-Dec-2016) | 634.1 m |
EV | 36.7 b |
Zimmer Biomet's current market capitalization is $26.1 b.
- Source: SEC Filings
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Revenue | 4.6 b | 4.7 b | 6 b | 7.7 b |
Revenue growth, % | 1% | 28% | 28% | |
Cost of goods sold | 1.3 b | 1.2 b | 1.8 b | 2.4 b |
Gross profit | 3.3 b | 3.4 b | 4.2 b | 5.3 b |
Gross profit Margin, % | 72% | 73% | 70% | 69% |
EBIT | 1 b | 1 b | 467.3 m | 825.9 m |
EBIT margin, % | 22% | 22% | 8% | 11% |
Interest income | 15.6 m | 11.9 m | 9.4 m | 2.9 m |
Pre tax profit | 981.1 m | 943.9 m | 153.2 m | 399.6 m |
Net Income | 759.2 m | 719 m | 146.2 m | 304.6 m |
- Source: SEC Filings
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash | 1.1 b | 1.1 b | 1.5 b | 634.1 m |
Inventories | 1.1 b | 1.2 b | 2.3 b | 2 b |
Current Assets | 4.2 b | 4.3 b | 5.9 b | 4.7 b |
PP&E | 1.2 b | 1.3 b | 2.1 b | 2 b |
Goodwill | 2.6 b | 2.5 b | 9.9 b | 10.6 b |
Total Assets | 9.6 b | 9.6 b | 27.2 b | 26.7 b |
Accounts Payable | 146.3 m | 167.1 m | 284.8 m | 364.5 m |
Total Debt | 1.7 b | 1.4 b | 11.6 b | 11.2 b |
Current Liabilities | 1 b | 1 b | 1.6 b | 2.4 b |
Additional Paid-in Capital | 4 b | 4.3 b | 8.2 b | 8.4 b |
Retained Earnings | 7.7 b | 8.3 b | 8.3 b | 8.5 b |
Total Equity | 6.3 b | 6.5 b | 9.9 b | 9.7 b |
Debt to Equity Ratio | 0.3 x | 0.2 x | 1.2 x | 1.2 x |
Debt to Assets Ratio | 0.2 x | 0.1 x | 0.4 x | 0.4 x |
Financial Leverage | 1.5 x | 1.5 x | 2.8 x | 2.8 x |
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | 759.2 m | 719 m | 146.2 m | 304.6 m |
Inventories | (128.4 m) | (154.1 m) | (205.4 m) | 76.4 m |
Cash From Operating Activities | 963.1 m | 1.1 b | 816.7 m | 1.6 b |
Cash From Investing Activities | (282.5 m) | (469.4 m) | (7.6 b) | (1.7 b) |
Cash From Financing Activities | (467.3 m) | (562.4 m) | 7.1 b | (743.2 m) |
Income Taxes Paid | 163.3 m | (10.9 m) |
| USD | Y, 2016 |
|---|---|
EV/EBIT | 44.5 x |
EV/CFO | 22.5 x |
Revenue/Employee | 426.9 k |
Debt/Equity | 1.2 x |
Debt/Assets | 0.4 x |
Financial Leverage | 2.8 x |
